Epidemiology of alcoholic and nonalcoholic fatty liver disease in China

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue SUPPL 1, 2013, Pages 11-17

  Fan, Jian Gao ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alcoholic liver disease; Diabetes mellitus; Fatty liver; Metabolic syndrome; Obesity

Indexed keywords

ALCOHOL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOLIC FATTY LIVER; CAUCASIAN; CHINA; CHRONIC LIVER DISEASE; DEVELOPED COUNTRY; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84880417614     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12036     Document Type: Review

References (73)

1. Chan HL, Jia J. Chronic hepatitis B in Asia-new insights from the past decade. J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 1): 131-137.
2. Cao HX, Fan JG. Fatty liver disease: a growing public health problem worldwide. J. Dig. Dis. 2011; 12: 1-2.
3. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009; 50: 204-210.
4. Chitturi S, Wong VW, Farrell G. Nonalcoholic fatty liver in Asia: firmly entrenched and rapidly gaining ground. J. Gastroenterol. Hepatol. 2011; 26 (Suppl. 1): 163-172.
5. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the study of liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55: 2005-2023.
6. O'Shea RS, Dasarathy S, McCullough AJ etal. Alcoholic liver disease. Hepatology 2010; 51: 307-328.
7. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2003; 11: 71.
8. Fatty Liver and Alcoholic Liver Disease Study Group, Chinese Liver Disease Association. Diagnostic criteria of alcoholic liver disease. Zhonghua Gan Zang Bing Za Zhi 2003; 11: 72.
9. Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. Guidelines for diagnosis and treatment alcoholic liver disease. Zhonghua Gan Zang Bing Za Zhi 2006; 14: 164-166.
10. Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases. Zhonghua Gan Zang Bing Za Zhi 2006; 14: 161-163.
11. Fan JG, Jia JD, Li YM etal. Guidelines for the diagnosis and management of non-alcoholic fatty liver disease: update 2010 Guidelines for the diagnosis and management of alcoholic liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 163-166). J. Dig. Dis. 2011; 12: 38-44.
12. Li YM, Fan JG, Wang BY etal. Guidelines for the diagnosis and management of alcoholic liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18: 167-170). J. Dig. Dis. 2011; 12: 45-50.
13. Fan JG. Steatohepatitis studies in China. Shijie Huaren Xiaohua Zazhi 2001; 9: 6-10.
14. Shen L, Fan JG, Shao Y etal. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J. Gastroenterol. 2003; 9: 1106-1110.
15. Fan JG, Li F, Cai XB etal. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J. Gastroenterol. Hepatol. 2007; 22: 663-668.
16. Wang Z, Xia B, Ma C etal. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, Central China. Postgrad. Med. J. 2007; 83: 192-195.
17. Zhang H, Jiang YF, He SM etal. Etiology and prevalence of abnormal serum alanine aminotransferase levels in a general population in Northeast China. Chin. Med. J. (Engl.) 2011; 124: 2661-2668.
18. Fung KT, Fung J, Lai CL, Yuen MF. Etiologies of chronic liver diseases in Hong Kong. Eur. J. Gastroenterol. Hepatol. 2007; 19: 659-664.
19. Fan JG, Zeng MD, Chen ZJ etal. Etiology analysis and its clinical features of 265 patients with fatty liver. Shanghai Yixie 1998; 18: 68-70.
20. Fan JG, Zhu J, Li XJ etal. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 2005; 43: 508-514.
21. Zhou YJ, Li YY, Nie YQ etal. Prevalence of fatty liver disease and its risk factors in the population of South China. World J. Gastroenterol. 2007; 13: 6419-6424.
22. Li H, Wang YJ, Tan K etal. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat. Dis. Int. 2009; 8: 377-382.
23. Shi XD, Wei Q, He SM etal. Epidemiology and analysis on risk factors of non-infectious chronic diseases in adults in northeast China. J. Jilin Univ. (Med. Ed.) 2011; 37: 379-384.
24. Wong VW, Chu WC, Wong GL etal. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012; 61: 409-415.
25. Wong VW, Wong GL, Chu WC etal. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol. 2012; 56: 533-540.
26. Shi J, Fan JG, Wu R etal. Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection. J. Gastroenterol. Hepatol. 2008; 23: 1419-1425.
27. Li YM, Chen WX, Yu CH etal. An epidemiological survey of alcoholic liver disease in Zhejiang Province. Zhonghua Gan Zang Bing Za Zhi 2003; 11: 647-649.
28. Lu XL, Tao M, Luo JY etal. Epidemiology of alcoholic liver diseases in Xi'an. Shijie Huaren Xiaohua Zazhi 2003; 11: 719-722.
29. Chen SL, Meng XD, Wang BY etal. An epidemiologic survey of alcoholic liver disease in some cities of Liaoning Province. Shiyong Ganzangbing Zazhi 2010; 13: 428-430.
30. Yao JH, Zhao QD, Xiong PF etal. Investigation of alcoholic liver disease in ethnic groups of Yuanjiang county in Yunman. Weichangbingxue He Ganbingxue Zazhi 2011; 20: 1137-1139.
31. Cooperative Group of Alcoholic Liver Disease. A multicenter study of alcoholic liver disease in China. Zhonghua Xiaohua Zazhi 2007; 27: 231-234.
32. Chen GH, Yang Y, Lu MQ etal. Liver transplantation for end-stage alcoholic liver disease: a single-center experience from mainland China. Alcohol 2010; 44: 217-221.
33. Wan YP, Xu RY, Fang H etal. The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai. Zhonghua Gan Zang Bing Za Zhi 2007; 15: 644-648.
34. Meng L, Luo N, Mi J. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children? Biomed. Environ. Sci. 2011; 24: 22-30.
35. Fu JF, Shi HB, Liu LR etal. Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children? World J. Gastroenterol. 2011; 17: 735-742.
36. Fan JG, Zhou Q, Wo QH etal. Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2010; 18: 676-679.
37. Zhou YJ, Li YY, Nie YQ, Huang CM, Cao CY. Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. J. Dig. Dis. 2012; 13: 153-160.
38. Hou XH, Zhu YX, Lu HJ etal. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J. Gastroenterol. Hepatol. 2011; 26: 722-730.
39. Leung CM, Lai LS, Wong WH etal. Non-alcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J. Gastroenterol. Hepatol. 2009; 24: 1786-1790.
40. Liew PL, Lee WJ, Lee YC etal. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes. Surg. 2006; 16: 1584-1593.
41. Shi JP, Xun YH, Su YX etal. Metabolic syndrome and severity of fibrosis in patients with chronic hepatitis B virus infection or nonalcoholic fatty liver disease. J. Microbiol. Res. 2011; 5: 481-485.
42. Wong VW, Wong GL, Tsang SW etal. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. Aliment. Pharmacol. Ther. 2009; 29: 387-396.
43. Duan XY, Qiao L, Fan JG. Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 2012; 11: 18-27.
44. Fan JG, Li F, Cai XB etal. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol. 2007; 22: 1086-1091.
45. Lu H, Zeng L, Liang B, Shu X, Xie D. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch. Med. Res. 2009; 40: 571-575.
46. Wong VW, Wong GL, Yip GW etal. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011; 60: 1721-1727.
47. Wong VW, Wong GL, Tsang SW etal. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60: 829-836.
48. Li M, Xu Y, Xu M etal. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J. Clin. Endocrinol. Metab. 2012; 97: 2033-2038.
49. Li G, Shi W, Hug H etal. Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population. Biochem. Med. (Zagreb) 2012; 22: 92-99.
50. Fan JG, Saibara T, Chitturi S etal. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J. Gastroenterol. Hepatol. 2007; 22: 794-800.
51. Fan JG, Zhu J, Li XJ etal. Fatty liver and the metabolic syndrome among Shanghai adults. J. Gastroenterol. Hepatol. 2005; 20: 1825-1832.
52. Zheng JS, Xu A, Huang T, Yu X, Li D. Low docosahexaenoic acid content in plasma phospholipids is associated with increased non-alcoholic fatty liver disease in China. Lipids 2012; 47: 549-556.
53. Liu S, Shi W, Li G etal. Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2011; 26: 1010-1015.
54. Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J. Hepatol. 2009; 50: 1029-1034.
55. Li G, Hu H, Shi W etal. Elevated hematocrit in nonalcoholic fatty liver disease: a potential cause for the increased risk of cardiovascular disease? Clin. Hemorheol. Microcirc. 2012; 51: 59-68.
56. Xu C, Xu L, Yu C, Miao M, Li Y. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin. Endocrinol. (Oxf.) 2011; 75: 240-246.
57. Zheng RH, Ding CF. Prevalence of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome: a case-control study. Zhonghua Fu Chan Ke Za Zhi 2008; 43: 98-101.
58. Shen Z, Li YM, Yu CH etal. Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study. World J. Gastroenterol. 2008; 14: 2255-2261.
59. Lu XL, Luo JY, Tao M etal. Risk factors for alcoholic liver disease in China. World J. Gastroenterol. 2004; 10: 2423-2426.
60. Fan JG, Cai XB, Li L etal. Alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation. World J. Gastroenterol. 2008; 14: 2418-2424.
61. Shen Z, Li Y, Yu C etal. A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels. Eur. J. Gastroenterol. Hepatol. 2010; 22: 820-825.
62. Hui Y, Yu-Yuan L, Yu-Qiang N etal. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people. Liver Int. 2008; 28: 385-392.
63. Yan X, Xu L, Qi J etal. sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics 2009; 61: 551-556.
64. Wang ZL, Xia B, Shrestha U etal. Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population. J. Endocrinol. Invest. 2008; 31: 1086-1091.
65. Lu H, Sun J, Sun L etal. Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China. J. Gastroenterol. Hepatol. 2009; 24: 228-232.
66. Yang Z, Wen J, Tao X etal. Genetic variation in the GCKR gene is associated with non-alcoholic fatty liver disease in Chinese people. Mol. Biol. Rep. 2011; 38: 1145-1150.
67. Zhou YJ, Li YY, Nie YQ etal. Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people. J. Gastroenterol. Hepatol. 2010; 25: 772-777.
68. Li Y, Xing C, Cohen JC, Hobbs HH. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. Hepatology 2012; 55: 327-328.
69. Peng XE, Wu YL, Lu QQ, Hu ZJ, Lin X. Two genetic variants in FABP1 and susceptibility to non-alcohol fatty liver disease in a Chinese population. Gene 2012; 500: 54-58.
70. Yang Z, Wen J, Li Q etal. PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. Mol. Cell. Endocrinol. 2012; 348: 255-259.
71. Yu C, Li Y, Chen W etal. Genotype of ethanol metabolizing enzyme genes by oligonucleotide microarray in alcoholic liver disease in Chinese people. Chin. Med. J. (Engl.) 2002; 115: 1085-1087.
72. Chen WX, Xu GY, Yu CH etal. Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease. Hepatobiliary Pancreat. Dis. Int. 2005; 4: 41-45.
73. Liu Y, Meng XW, Zhou LY etal. Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. Hepatobiliary Pancreat. Dis. Int. 2009; 8: 162-167.